Rhodes, Stephen
Sahmoud, Amine
Jelovsek, J. Eric
Bretschneider, C. Emi
Gupta, Ankita
Hijaz, Adonis K.
Sheyn, David https://orcid.org/0000-0003-1030-3067
Article History
Received: 16 September 2024
Accepted: 5 December 2024
First Online: 7 January 2025
Declarations
:
: D.S.: consulting fee for Caldera Medical; research support for Medtronic, Axonics, Renalis, Vikor Scientific; advisory board for CollaMedix; grant funding from NICHD, NIA, AHRQ, PCORI. A.K.H.: stock in CollaMedix; grant funding from NICHD, AHRQ, Revi. C.E.B.: consulting fee for Boston Scientific. J.E.J.: grant funding from NIDDK and NICHD; royalties from UpToDate; advisory board for CollaMedix. The remaining authors do not report any conflicts of interest.